Results 161 to 170 of about 963 (180)

Acute and subchronic effects of bilastine (20 and 40 mg) and hydroxyzine (50 mg) on actual driving performance in healthy volunteers

Journal of Psychopharmacology, 2011
Silke Conen, Eef Theunissen, Johannes Ramaekers   +2 more
exaly  

Bilastine. Preclinical toxicology review

Toxicology Letters, 2010
J. Arteche, F. Ledo, A. Casadesus, L. Canut, F. Gomez, A. Tortajada, M.L. Lucero   +6 more
openaire   +1 more source

Process and intermediates for the preparation of bilastine

2020
HERNÁNDEZ HERRERO GONZALO, GARCÍA DOMÍNGUEZ NEFTALÍ, MORÁN POLADURA PABLO, GONZÁLEZ GARCÍA TANIA, GANZA GONZÁLEZ ÁLVARO, TATO CERDEIRAS PALOMA   +5 more
openaire   +4 more sources

Bilastine: Impurities safety profile

Toxicology Letters, 2010
A. Alejandro, J. Arteche, F. Ledo, A. Leizea, M.T. Nuñez, P. Vilches, M.L. Lucero   +6 more
openaire   +1 more source

Safety and tolerability of bilastine 10 mg administered for 12 weeks in children with allergic diseases

Pediatric Allergy and Immunology, 2016
Ana Margarida Pereira, Magdalena Mroczek, Davor Plavec   +2 more
exaly  

Bilastine/dexpanthenol

Reactions Weekly
openaire   +1 more source

Bilastine: Environmental risk assessment

Toxicology Letters, 2010
F. Ledo, M.L. Lucero, B. Seyfred, M. Weissenfeld, W. Megel, A. Peither, P. Roulstone, T. Schoop, E. Kiefer   +8 more
openaire   +1 more source

Bilastine/deflazacort

Reactions Weekly
openaire   +1 more source

The long duration of action of the second generation antihistamine bilastine coincides with its long residence time at the histamine H1 receptor

European Journal of Pharmacology, 2018
Henry Vischer, Jelle van den Bor, Rob Leurs   +2 more
exaly  

Bilastine/Omalizumab

Reactions Weekly
openaire   +1 more source